Picture of Biocon logo

BIOCON Biocon Income Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapFalling Star

Annual income statement for Biocon, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2018
March 31st
2019
March 31st
R2020
March 31st
R2021
March 31st
2022
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSInterim ReportInterim ReportARS
Standards:
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue41,29755,14463,00571,43181,840
Cost of Revenue
Gross Profit22,18332,70039,38144,91349,785
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses36,85745,68551,80860,25870,795
Operating Profit4,4409,45911,19711,17311,045
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes6,10012,14912,14910,6779,831
Provision for Income Taxes
Net Income After Taxes4,53110,0268,9988,4627,716
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income3,7249,0537,4827,4056,484
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income3,7249,0537,4827,4056,484
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS3.147.76.135.15.97
Dividends per Share

Or unlock with your email

Or unlock with your email